Home ProductsRemdesivir Powder

Cas 159326-68-8 Remdesivir Powder Pyrrolo 1 2-F 1 2 4 Triazin-4-Amine

Cas 159326-68-8 Remdesivir Powder Pyrrolo 1 2-F 1 2 4 Triazin-4-Amine

    • Cas 159326-68-8 Remdesivir Powder Pyrrolo 1 2-F 1 2 4 Triazin-4-Amine
    • Cas 159326-68-8 Remdesivir Powder Pyrrolo 1 2-F 1 2 4 Triazin-4-Amine
  • Cas 159326-68-8 Remdesivir Powder Pyrrolo 1 2-F 1 2 4 Triazin-4-Amine

    Product Details:

    Place of Origin: China
    Brand Name: Leji
    Model Number: Remedesivir Intermediate

    Payment & Shipping Terms:

    Minimum Order Quantity: Negotiation
    Price: Negotiation
    Packaging Details: Aluminum Foil Bag, barrel, or drum.
    Delivery Time: 7-15 working days
    Payment Terms: T/T, western union, moneygram
    Supply Ability: 5 - 25 metric ton per month
    Contact Now
    Detailed Product Description
    Other Names: Remedesivir Intermediate Appearance: White Powder
    Application: Virus Treatment Cas No.: 159326-68-8
    Mf: C6H6N4 Density: 1.50
    High Light:

    pharmaceutiacal remdesivir

    ,

    remdesivir intermediate

    Cas 159326-68-8 Remdesivir Intermediates Powder Pyrrolo[1,2-F][1,2,4]Triazin-4-Amine

     

    Description

       Remdesivir is a nucleoside analogue and is an RNA-dependent RNA polymerase (RdRp) inhibitor. It can synthesize antivirals by
    inhibiting viral nucleic acids. A clinical  bed study for Ebola virus infection is currently in phase II.
    MERS-infected mice performed much better with this combination therapy, with reduced virus replication and improved lung function.
    Recent studies have shown that Radixivir has a certain activity in inhibiting the new crown virus.

     

     

     

    Product Parameters

     

    cas 159326-68-8
    Name PYRROLO[1,2-F][1,2,4]TRIAZIN-4-AMINE
    Appearance White powder
    Application Pharmaceutical Intermediates

     

      

    Application

     

       Remdesivir is a nucleotide analogue prodrug. In vitro experiments and animal model data showed that Remdesivir inhibited RNA dependent RNA synthetase (RdRp), including SARS coronavirus, mers coronavirus, Ebola coronavirus and many other coronaviruses. A novel coronavirus in Reed cell was found to have a median effective concentration (IC50) of 0.77 mol L-1. However, Remdesivir has not been approved for marketing in any country, and its effectiveness and safety have not been confirmed by phase III clinical trials. Only phase II clinical trials are conducted for Ebola virus.

     

    FAQ

     

    Q1: How long is your delivery time?

     

    A: Prompt shipment after receipt of order confirmation for regular products. Generally it is 1-5 days if the goods are in stock. or it is 5-15 days if the goods are not in stock, it is according to quantity.

     
    Q2: How much for the freight?
     
    A: It depends on your area, we will use DHL, FedEx and EMS bulk service, it had discount as normal express service.
     
    Q3: How can i release the payment to you?
     
    A: We can receive your payment by T/T, moneygram or Western union which is recommended.

     

    Contact Details
    Wuxi Leji Biological Technology Co., Ltd

    Contact Person: Max

    Send your inquiry directly to us (0 / 3000)